$365 Thousand is the total value of Sands Capital Ventures, LLC's 24 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | DICE THERAPEUTICS, INC. | $85,768 | -99.9% | 2,748,970 | -12.7% | 23.49% | +26.6% | |
| PATH | Buy | UIPATH INC | $48,509 | -99.9% | 3,816,569 | +0.1% | 13.29% | -4.9% |
| Buy | NU HOLDINGS LTD. | $37,266 | -99.9% | 9,156,347 | +0.2% | 10.21% | -12.6% | |
| SAMSARA, INC. | $33,713 | -99.9% | 2,712,256 | 0.0% | 9.23% | -3.0% | ||
| SNOW | Buy | SNOWFLAKE INC | $30,938 | -99.9% | 215,535 | +0.4% | 8.47% | -20.1% |
| DASH | Buy | DOORDASH INC | $29,463 | -99.9% | 603,512 | +0.3% | 8.07% | -6.7% |
| New | ACRIVON THERAPEUTICS, INC. | $19,038 | – | 1,652,605 | +100.0% | 5.21% | – | |
| ABOS | ACUMEN PHARMACEUTICALS, INC | $18,452 | -99.9% | 3,417,075 | 0.0% | 5.05% | -49.3% | |
| OLK | OLINK HOLDING AB | $17,906 | -99.8% | 705,514 | 0.0% | 4.90% | +97.0% | |
| TXG | 10X Genomics, Inc. | $17,556 | -99.9% | 481,770 | 0.0% | 4.81% | +20.6% | |
| KRTX | KARUNA THERAPEUTICS, INC. | $11,573 | -99.9% | 58,895 | 0.0% | 3.17% | -17.7% | |
| Buy | SAMSARA, INC. | $4,133 | -99.9% | 332,520 | +2.0% | 1.13% | -1.0% | |
| TARS | TARSUS PHARMACEUTICALS INC | $3,812 | -99.9% | 260,000 | 0.0% | 1.04% | -19.3% | |
| MASS | 908 DEVICES INC | $2,487 | -100.0% | 326,427 | 0.0% | 0.68% | -56.4% | |
| TSHA | TAYSHA GENE THERAPIES INC | $1,638 | -99.9% | 724,873 | 0.0% | 0.45% | +10.3% | |
| CANDEL THERAPEUTICS, INC | $1,453 | -99.9% | 811,737 | 0.0% | 0.40% | -46.3% | ||
| SPRB | SPRUCE BIOSCIENCES INC | $866 | -99.9% | 787,007 | 0.0% | 0.24% | -24.3% | |
| ABSCI CORP. | $121 | -99.9% | 57,804 | 0.0% | 0.03% | -37.7% | ||
| CPNG | New | COUPANG INC | $103 | – | 6,971 | +100.0% | 0.03% | – |
| DDOG | New | DATADOG INC | $100 | – | 1,366 | +100.0% | 0.03% | – |
| CRWD | New | CROWDSTRIKE HOLDINGS INC | $91 | – | 864 | +100.0% | 0.02% | – |
| New | TOAST INC | $81 | – | 4,494 | +100.0% | 0.02% | – | |
| New | GITLAB INC. | $30 | – | 658 | +100.0% | 0.01% | – | |
| CFLT | New | CONFLUENT INC CLASS A - ADR | $30 | – | 1,354 | +100.0% | 0.01% | – |
| RGEN | Exit | REPLIGEN CORP. | $0 | – | -22,544 | -100.0% | -1.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UIPATH INC | 9 | Q3 2023 | 30.2% |
| DOORDASH INC | 9 | Q3 2023 | 19.6% |
| SNOWFLAKE INC | 9 | Q3 2023 | 14.4% |
| ACUMEN PHARMACEUTICALS, INC | 9 | Q3 2023 | 10.0% |
| 908 DEVICES INC | 9 | Q3 2023 | 1.8% |
| TARSUS PHARMACEUTICALS INC | 9 | Q3 2023 | 1.4% |
| TAYSHA GENE THERAPIES INC | 9 | Q3 2023 | 2.0% |
| CANDEL THERAPEUTICS, INC | 9 | Q3 2023 | 1.3% |
| SPRUCE BIOSCIENCES INC | 9 | Q3 2023 | 0.7% |
| ABSCI CORPORATION | 9 | Q3 2023 | 0.1% |
View Sands Capital Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-15 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-09 |
View Sands Capital Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.